Filing Flows › Tandem Diabetes Care (TNDM) › Guidance history
Tandem Diabetes Care (TNDM) guidance history: what it guided and what it reported
Tandem Diabetes Care gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance 0 times and lowered it once.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $1.1B–$1.1B (May 7, 2026) → reaffirmed $1.1B–$1.1B (Aug 6, 2026) → reaffirmed $1.1B–$1.1B (Nov 5, 2026) | — | to be reported | — |
Operating expenses
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $100M (May 7, 2026) → lowered $85.0M (Aug 6, 2026) → reaffirmed $85.0M (Nov 5, 2026) | — | to be reported | — |
The latest quarter
Tandem Diabetes Care, Q3 2026: revenue $284M (+14% year over year), operating margin -0.8%, net loss $7.1M, operating cash flow −$819K. The chart follows the revenue to costs, profit and cash.
Questions
Does Tandem Diabetes Care beat its guidance?
Tandem Diabetes Care gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance 0 times and lowered it once.
How often does Tandem Diabetes Care raise guidance?
Its earnings releases raised guidance 0 times and lowered it once since May 7, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.